X4 Pharmaceuticals Company
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Last Funding Date:
2021
Technology:
Data-driven Technologies
Last Funding Type:
Post-IPO Equity
Investors Number:
12
Industry:
Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics
Founded Date:
2014
Investor Type:
IPO
Employee Number:
51-100
Total Funding:
119499999
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
Less than $1M
Funding Status:
IPO